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Background. There are few reports of pregnancies in long-term survivors of pelvic neuroblastoma. Case. A 30-year-old Japanese
woman with a history of pelvic neuroblastoma in her childhood, which was treated with surgical resection, chemotherapy, and
radiation.Herpregnancycontinuedwithconservativemanagement,butshedelivereda510gfemaleinfantat23weeksofgestation
due to sudden onset of labor pain. She also had a placental polyp and developed massive postpartum bleeding. Conclusion.C a n c e r
treatment, especially radiation therapy, in childhood may cause adverse outcomes during pregnancy in long-term survivors of
neuroblastoma.
Copyright © 2009 Noriyoshi Watanabe et al. This is an open access article distributed under the Creative Commons Attribution
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1.Introduction
Treatment for childhood cancer has become increasingly
successful. Approximately 70% of patients with childhood
cancer survive for 5 years, and many long-term survivors are
now reaching adulthood [1]. Neuroblastoma is a childhood
cancer that originates in the adrenal glands in more than
90% of cases. Pelvic neuroblastoma is thought to have a good
prognosis, but women who have previously been treated
withcurativesurgery,chemotherapy,orradiationmighthave
long-term eﬀects on their reproductive organs. There are
few reports of pregnancies in women who have previously
been treated for neuroblastoma. Here, we report a case of a
pregnant patient who had been successfully treated for pelvic
neuroblastoma.
2.CaseReport
The patient was a 30-year-old Japanese woman. This was her
ﬁrst pregnancy. She had a pelvic neuroblastoma in the front
of her sacrum at 1 month of age. She had undergone sur-
gical resection, and the pathology revealed rosette-forming
neuroblastoma. She received adjuvant chemotherapy with
vincristine and cyclophosphamide (the James method) post-
operatively up to the age of 2 years. She also received pelvic
irradiation with a total dose of 18Gy. By age of 3 years, there
was no evidence of disease, and she was considered cured.
Shevisitedouthospitalforprenatalcareat6weeksofges-
tation.At15weeksand5daysofgestation,shecomplainedof
abdominalpainduetofrequentuterinecontractionsandwas
diagnosed with threatened abortion or incompetent cervix
by transvaginal ultrasound. She was admitted at 16 weeks
of gestation and ritodrine tocolytic therapy was initiated
to control her frequent uterine contractions. At 20 weeks
and 2 days of gestation, she developed acute abdominal
pain. Ultrasound and magnetic resonance imaging (MRI)
revealed intra-abdominal bleeding of unknown etiology
(Figure 1). The patient and her husband chose to continue
the pregnancy even after we explained to them the risks
involved in doing so and after we suggested termination
of pregnancy. She received 4 units of red blood cells but
did not require any surgical intervention. At 23 weeks of
gestation, she prematurely delivered a 510g female infant
due to sudden onset of labor pain. There were no signs of2 Obstetrics and Gynecology International
Figure 1: MRI at 21 weeks of gestation. Arrows show location of
intra-abdominal bleeding.
chorioamnionitis. The infant was admitted to the NICU and
was discharged in good condition 110 days after birth.
The patient presented with massive vaginal bleeding
14 days postpartum. Medical and surgical therapy was
performed. Uterine curettage revealed a retained placenta.
Despitethesetreatments,thepatientexperiencedcontinuous
slow vaginal bleeding. However, because her bleeding was
light, she waited to see if the bleeding would stop naturally.
An MRI was conducted at 46 days postpartum, and the scan
revealed a placental polyp (Figure 2). Heavy vaginal bleeding
occurred at 49 days postpartum. Uterine artery embolization
(UAE) was considered, but the patient was noted to shed the
placental polyp spontaneously with full recovery.
3. Discussion
Long-term female survivors of childhood pelvic neuroblas-
toma might develop complications during pregnancy due to
the negative eﬀects of prior radiation therapy. Our patient
received postoperative chemotherapy with vincristine and
cyclophosphamide without apparent eﬀects on her preg-
nancy. Green et al. [2] reported that prior treatment with
speciﬁed chemotherapeutic agents does not aﬀect subse-
quent pregnancy; this ﬁnding is also supported by other
studies.
Critchley andWallace[3]reported that radiation therapy
could have negative eﬀects on the uterus. Speciﬁcally, they
reported that radiation doses between 14 and 30Gy resulted
in the impairment of uterine musculature and vasculature
and that patient age at the time of irradiation determined
the ﬁnal uterine volume. Our patient delivered at 23 weeks
of gestation. Most preterm labor is due to chorioamnionitis;
but no evidence of infection was found in our patient. It is
possible that the prior radiation to her pelvis resulted in an
underdeveloped uterus with subsequent preterm labor and
delivery [3, 4]. In this case, because we did not measure
Figure 2: MRI at 47 days after delivery. Arrows point to placental
polyp.
her uterine volume, we have no evidence to prove that her
uterus was underdeveloped. However, Critchley and Wallace
[3] reported that a patient treated with radiation prior to
pubertyhadasmalluterus.Therefore,wespeculatedthatour
patient’s uterus was underdeveloped.
It is possible that the patient’s intra-abdominal bleeding
might have been a negative consequence of prior radiation.
Our patient developed sudden intra-abdominal bleeding at
20 weeks of gestation. The cause is unclear because we
did not perform any surgical intervention. The surgery
and pelvic irradiation that she underwent in her childhood
causedadhesioninherabdomen,andthisadhesionmayhave
torn as the uterus extended during pregnancy, resulting in
intra-abdominal bleeding at 20 weeks of gestation.
In this case, pregnancy termination might have to be
considered to avoid the associated risk of continuing the
pregnancy. We decided to continue her pregnancy for 2
reasons: (i) the patient was determined to give birth to a
living infant, and (ii) this pregnancy might have been her last
chancetodeliverababybecausethisatypicalcomplication—
intra-abdominal bleeding during her pregnancy—was an
eﬀect of pelvic irradiation in her childhood.
Uterine irradiation might predispose a woman to abnor-
mal placentation in a subsequent pregnancy. Norwitz et al.
[5] reported a patient with a history of abdominal radiation
who experienced placenta percreta and uterine rupture at
17 weeks of gestation. Our patient suﬀered from placental
polyps at almost 2 months postpartum. This ﬁnding is also
consistent with abnormal placentation and is a likely result
of her childhood radiation therapy.
In summary, pregnancy outcomes may be aﬀected in
long-term survivors of childhood cancers who have received
pelvic radiation. Obtaining a detailed history is essential to
manage the pregnancies of such patients. Patients with a
history of prior pelvic radiation might experience decreased
uterine volume and increased risks of miscarriage, pretermObstetrics and Gynecology International 3
delivery,orabnormalplacentationandshouldreceiveappro-
priate high-risk prenatal care.
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